296 related articles for article (PubMed ID: 17345064)
1. Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers.
Reid MS; Palamar J; Raghavan S; Flammino F
Psychopharmacology (Berl); 2007 May; 192(1):147-58. PubMed ID: 17345064
[TBL] [Abstract][Full Text] [Related]
2. Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers.
Sofuoglu M; Poling J; Mouratidis M; Kosten T
Psychopharmacology (Berl); 2006 Mar; 184(3-4):645-51. PubMed ID: 16432681
[TBL] [Abstract][Full Text] [Related]
3. Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation.
Anthenelli RM; Blom TJ; McElroy SL; Keck PE
Addiction; 2008 Apr; 103(4):687-94. PubMed ID: 18339115
[TBL] [Abstract][Full Text] [Related]
4. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
5. An acute dose of nicotine enhances cue-induced cocaine craving.
Reid MS; Mickalian JD; Delucchi KL; Hall SM; Berger SP
Drug Alcohol Depend; 1998 Jan; 49(2):95-104. PubMed ID: 9543646
[TBL] [Abstract][Full Text] [Related]
6. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
7. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
West R; Baker CL; Cappelleri JC; Bushmakin AG
Psychopharmacology (Berl); 2008 Apr; 197(3):371-7. PubMed ID: 18084743
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.
Rose JE; Behm FM; Westman EC
Pharmacol Biochem Behav; 2001 Feb; 68(2):187-97. PubMed ID: 11267622
[TBL] [Abstract][Full Text] [Related]
9. Does acute tobacco smoking prevent cue-induced craving?
Schlagintweit HE; Barrett SP
J Psychopharmacol; 2016 May; 30(5):468-73. PubMed ID: 27026532
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
Jones JD; Babalonis S; Marcus R; Vince B; Kelsh D; Lofwall MR; Fraser H; Paterson B; Martinez S; Martinez DM; Nunes EV; Walsh SL; Comer SD
Addict Biol; 2020 Jul; 25(4):e12799. PubMed ID: 31240842
[TBL] [Abstract][Full Text] [Related]
11. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
[TBL] [Abstract][Full Text] [Related]
12. The impact of cigarette deprivation and cigarette availability on cue-reactivity in smokers.
Bailey SR; Goedeker KC; Tiffany ST
Addiction; 2010 Feb; 105(2):364-72. PubMed ID: 19922514
[TBL] [Abstract][Full Text] [Related]
13. Effects of varenicline on smoking cue–triggered neural and craving responses.
Franklin T; Wang Z; Suh JJ; Hazan R; Cruz J; Li Y; Goldman M; Detre JA; O'Brien CP; Childress AR
Arch Gen Psychiatry; 2011 May; 68(5):516-26. PubMed ID: 21199958
[TBL] [Abstract][Full Text] [Related]
14. Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.
Sofuoglu M; Herman AI; Li Y; Waters AJ
Psychopharmacology (Berl); 2012 Dec; 224(3):413-20. PubMed ID: 22700039
[TBL] [Abstract][Full Text] [Related]
15. Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers.
Tiffany ST; Cox LS; Elash CA
J Consult Clin Psychol; 2000 Apr; 68(2):233-40. PubMed ID: 10780123
[TBL] [Abstract][Full Text] [Related]
16. Topiramate for smoking cessation.
Khazaal Y; Cornuz J; Bilancioni R; Zullino DF
Psychiatry Clin Neurosci; 2006 Jun; 60(3):384-8. PubMed ID: 16732758
[TBL] [Abstract][Full Text] [Related]
17. Intolerance for smoking abstinence among nicotine-deprived, treatment-seeking smokers.
Germeroth LJ; Baker NL; Saladin ME
Addict Behav; 2018 Sep; 84():13-19. PubMed ID: 29597136
[TBL] [Abstract][Full Text] [Related]
18. Effect of deactivation of activity patterns related to smoking cue reactivity on nicotine addiction.
Bu J; Young KD; Hong W; Ma R; Song H; Wang Y; Zhang W; Hampson M; Hendler T; Zhang X
Brain; 2019 Jun; 142(6):1827-1841. PubMed ID: 31135053
[TBL] [Abstract][Full Text] [Related]
19. Dissociable effect of acute varenicline on tonic versus cue-provoked craving in non-treatment-motivated heavy smokers.
Hitsman B; Hogarth L; Tseng LJ; Teige JC; Shadel WG; DiBenedetti DB; Danto S; Lee TC; Price LH; Niaura R
Drug Alcohol Depend; 2013 Jun; 130(1-3):135-41. PubMed ID: 23201174
[TBL] [Abstract][Full Text] [Related]
20. Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2005 Nov; 183(1):1-12. PubMed ID: 16160876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
